( Nasdaq : CEPH ) announced today that it has completed its previously announced acquisition of all of the outstanding ordinary shares of Australian biotechnology company , Arana Therapeutics Limited . As a result of the acquisition , Arana is now a wholly-owned subsidiary of Cephalon .